Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Medical technology & services

OptiBiotix Health - the commercial momentum continues to build

After a string of deals for its health products, including one earlier this week, the company said it had inked an exclusive agreement in Poland

The commercial momentum at OptiBiotix Health PLC (LON:OPTI) continues to build.

After a string of deals for its health products, including one earlier this week, the company said it had inked an exclusive agreement in Poland.

The tie-up gives local operator Extensor the rights to distribute OptiBiotix’s GoFigure weight management line across the country.

Sales and marketing director, Christina Wood, said: “This is the first step in taking OptiBiotix's own label GoFigure products to international markets.

“This increases brand recognition and value in addition to creating a demand for SlimBiome, the functional ingredient within GoFigure products.

“This means we are able to derive revenue from both the sale of our own brand GoFigure products and SlimBiome."

Focused on the human microbiome, OptiBiotics has developed a series of products and potential treatments focused on changing the gut flora to tackle obesity, high cholesterol and diabetes.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK